| P50 | author | Linda E Amoah | Q89635448 |
| P2093 | author name string | Kim C Williamson | |
| | Acquah, F.K. | |
| | Amoah, L.E. | |
| | Festus K Acquah | |
| | Williamson, K.C. | |
| | Adjah, J. | |
| | Joshua Adjah | |
| P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
| | Algae-produced Pfs25 elicits antibodies that inhibit malaria transmission | Q21134576 |
| | The cell biology of malaria infection of mosquito: advances and opportunities | Q27024179 |
| | Naturally occurring antibodies to an epitope on Plasmodium falciparum gametes detected by monoclonal antibody-based competitive enzyme-linked immunosorbent assay | Q27487442 |
| | Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes | Q27860838 |
| | RIFINs are adhesins implicated in severe Plasmodium falciparum malaria | Q27972159 |
| | Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum | Q27972160 |
| | The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system | Q27973784 |
| | Plasmodium falciparum evades mosquito immunity by disrupting JNK-mediated apoptosis of invaded midgut cells | Q27973785 |
| | The March Toward Malaria Vaccines | Q28084325 |
| | Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers | Q28482471 |
| | PlasmoDB: a functional genomic database for malaria parasites | Q29618004 |
| | Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes | Q29618254 |
| | A proteomic view of the Plasmodium falciparum life cycle | Q29618807 |
| | Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes | Q29618991 |
| | Targeting malaria virulence and remodeling proteins to the host erythrocyte | Q29620631 |
| | Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum | Q30042317 |
| | Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230 | Q30042991 |
| | Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity | Q30042993 |
| | A central role for P48/45 in malaria parasite male gamete fertility | Q30043154 |
| | Pfs47, paralog of the male fertility factor Pfs48/45, is a female specific surface protein in Plasmodium falciparum | Q30043157 |
| | SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes | Q30043677 |
| | PEXEL-independent trafficking of Plasmodium falciparum SURFIN4.2 to the parasite-infected red blood cell and Maurer's clefts | Q30043679 |
| | Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230. | Q30390705 |
| | SURFIN4.1, a schizont-merozoite associated protein in the SURFIN family of Plasmodium falciparum | Q31161094 |
| | Sub-grouping and sub-functionalization of the RIFIN multi-copy protein family | Q33314965 |
| | Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte | Q33338492 |
| | The Plasmodium falciparum STEVOR multigene family mediates antigenic variation of the infected erythrocyte | Q33410790 |
| | A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli | Q33485233 |
| | Distinct trafficking and localization of STEVOR proteins in three stages of the Plasmodium falciparum life cycle | Q37582797 |
| | Revisiting the Plasmodium falciparum RIFIN family: from comparative genomics to 3D-model prediction | Q33505456 |
| | Evidence for specific suppression of gametocytemia by Plasmodium falciparum in residents of hyperendemic Irian Jaya | Q33528315 |
| | Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility | Q33553363 |
| | A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies | Q33591209 |
| | Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow | Q33794320 |
| | New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission | Q33801989 |
| | Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs | Q33898575 |
| | Identification of a major rif transcript common to gametocytes and sporozoites of Plasmodium falciparum | Q33934212 |
| | Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies | Q34000822 |
| | Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes | Q34005142 |
| | Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum | Q34086895 |
| | The Plasmodium bottleneck: malaria parasite losses in the mosquito vector | Q34142771 |
| | Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates | Q34161839 |
| | Differential adhesive properties of sequestered asexual and sexual stages of Plasmodium falciparum on human endothelial cells are tissue independent | Q34171103 |
| | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | Q34177472 |
| | Plasmodium falciparum transmission stages accumulate in the human bone marrow | Q34245311 |
| | Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes | Q34256662 |
| | CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum | Q34521530 |
| | Decoding the language of var genes and Plasmodium falciparum sequestration | Q34548667 |
| | Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays | Q34618434 |
| | Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay | Q34995863 |
| | Malaria parasite Pfs47 disrupts JNK signaling to escape mosquito immunity | Q35062675 |
| | Regulation of sexual development of Plasmodium by translational repression | Q35090746 |
| | Virulence and transmission success of the malarial parasite Plasmodium falciparum | Q35132510 |
| | N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity | Q35138720 |
| | A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum | Q35138735 |
| | Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind | Q35200263 |
| | Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes | Q35439931 |
| | A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines | Q35544571 |
| | Pfs230: from malaria transmission-blocking vaccine candidate toward function | Q35548285 |
| | Regulating the adaptive immune response to blood-stage malaria: role of dendritic cells and CD4⁺Foxp3⁺ regulatory T cells | Q35565165 |
| | Sequestration: causes and consequences | Q35666823 |
| | Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum | Q35718341 |
| | Protein export in malaria parasites: do multiple export motifs add up to multiple export pathways? | Q37625114 |
| | The Ancient Gamete Fusogen HAP2 Is a Eukaryotic Class II Fusion Protein | Q37675742 |
| | Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding | Q37713285 |
| | Plasmodium falciparum gametocytes: with a view to a kill. | Q38129536 |
| | The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification | Q38520062 |
| | Development of vaccines for Plasmodium vivax malaria | Q38597276 |
| | The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle | Q38789240 |
| | Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay | Q38845963 |
| | Evidence of non-neutral polymorphism in Plasmodium falciparum gamete surface protein genes Pfs47 and Pfs48/45. | Q38876779 |
| | The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. | Q38942070 |
| | Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children | Q38977779 |
| | Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates | Q39018502 |
| | Development and host cell modifications of Plasmodium falciparum blood stages in four dimensions. | Q39034766 |
| | Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes | Q39141585 |
| | Limited polymorphism in Plasmodium falciparum sexual-stage antigens | Q39304090 |
| | Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso | Q39331193 |
| | Variant proteins of the Plasmodium falciparum RIFIN family show distinct subcellular localization and developmental expression patterns | Q39352490 |
| | Variant surface antigens of Plasmodium falciparum and their roles in severe malaria | Q39365658 |
| | A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. | Q39405774 |
| | A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies | Q39467691 |
| | Stevor transcripts from Plasmodium falciparum gametocytes encode truncated polypeptides | Q39500191 |
| | Plasmodium vivax gametocyte proteins, Pvs48/45 and Pvs47, induce transmission-reducing antibodies by DNA immunization | Q39504399 |
| | Plasmodium falciparum sexual stage antigens: Immunogenicity and cell-mediated responses | Q39511780 |
| | A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages | Q39520295 |
| | The N-terminal segment of Plasmodium falciparum SURFIN4.1 is required for its trafficking to the red blood cell cytosol through the endoplasmic reticulum | Q39631308 |
| | Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent | Q39821154 |
| | Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development | Q40102169 |
| | Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana | Q40110842 |
| | An N-terminal Pfs230 domain produced in baculovirus as a biological active transmission-blocking vaccine candidate | Q40118467 |
| | New observations on gametogenesis, fertilization, and zygote transformation in Plasmodium gallinaceum | Q41579335 |
| | Development of a malaria vaccine | Q41662362 |
| | Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate | Q41989340 |
| | Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals | Q42006764 |
| | Development of a single-replicon miniBYV vector for co-expression of heterologous proteins | Q42184797 |
| | The extravascular compartment of the bone marrow: a niche for Plasmodium falciparum gametocyte maturation? | Q42424857 |
| | Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes | Q43032460 |
| | Induction of plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus | Q43409506 |
| | A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains | Q43525538 |
| | Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii | Q43645737 |
| | A comparative study of the localization and membrane topology of members of the RIFIN, STEVOR and PfMC-2TM protein families in Plasmodium falciparum-infected erythrocytes | Q35853627 |
| | Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine. | Q35867612 |
| | Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen | Q35941338 |
| | Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer | Q35982771 |
| | The Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope | Q35989209 |
| | A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages | Q36057631 |
| | Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure | Q36138015 |
| | Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults | Q36165265 |
| | Pexel/VTS: a protein-export motif in erythrocytes infected with malaria parasites. | Q36208248 |
| | Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum | Q36348052 |
| | Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito | Q36351262 |
| | Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies | Q36355913 |
| | Pfs2400 can mediate antibody-dependent malaria transmission inhibition and may be the Plasmodium falciparum 11.1 gene product | Q36361341 |
| | Plasmodium evasion of mosquito immunity and global malaria transmission: The lock-and-key theory | Q36371372 |
| | Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses | Q36375576 |
| | Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology | Q36442817 |
| | Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens | Q36455757 |
| | Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes | Q36531224 |
| | Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates | Q36539678 |
| | The conserved plant sterility gene HAP2 functions after attachment of fusogenic membranes in Chlamydomonas and Plasmodium gametes | Q36585513 |
| | A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. | Q36595999 |
| | Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice | Q36670217 |
| | Gamete vaccines and transmission-blocking immunity in malaria | Q36674753 |
| | Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials | Q36800842 |
| | Plasmodium falciparum variant STEVOR antigens are expressed in merozoites and possibly associated with erythrocyte invasion | Q36853127 |
| | Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans | Q37016257 |
| | Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates | Q37170062 |
| | An inter-laboratory comparison of standard membrane-feeding assays for evaluation of malaria transmission-blocking vaccines | Q37243605 |
| | A humanized mouse model for sequestration of Plasmodium falciparum sexual stages and in vivo evaluation of gametocytidal drugs | Q37330567 |
| | Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay | Q37336089 |
| | Antibody responses to surface antigens of Plasmodium falciparum gametocyte-infected erythrocytes and their relation to gametocytaemia | Q37384816 |
| | Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? | Q37487002 |
| | Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria | Q37546481 |
| | Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro | Q37549510 |
| | Early gametocytes of the malaria parasite Plasmodium falciparum specifically remodel the adhesive properties of infected erythrocyte surface | Q43713662 |
| | High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. | Q43936049 |
| | Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers | Q43946977 |
| | Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania | Q43951299 |
| | Target antigens of malaria transmission blocking immunity exist as a stable membrane bound complex | Q44027193 |
| | Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon | Q44137386 |
| | Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum | Q44143594 |
| | The 230-kDa gamete surface protein of plasmodium falciparum is also a target for transmission-blocking antibodies | Q44146561 |
| | Antibodies to plasmodium falciparum gamete surface antigens in papua new guinea sera | Q44150700 |
| | Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activity | Q44156482 |
| | Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate | Q44161927 |
| | Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing | Q44168384 |
| | Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production | Q44169388 |
| | Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques | Q44169836 |
| | The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials | Q44170388 |
| | Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates | Q44172461 |
| | Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes | Q44173322 |
| | Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidate | Q44173710 |
| | Plasmodium P47: a key gene for malaria transmission by mosquito vectors | Q46243567 |
| | Targeting the Conserved Fusion Loop of HAP2 Inhibits the Transmission of Plasmodium berghei and falciparum | Q46246718 |
| | Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium | Q47106697 |
| | Common trafficking pathway for variant antigens destined for the surface of the Plasmodium falciparum-infected erythrocyte | Q47328565 |
| | Quantitative Proteomic Profiling Reveals Novel Plasmodium falciparum Surface Antigens and Possible Vaccine Candidates | Q47377549 |
| | Epitope analysis of the malaria surface antigen pfs48/45 identifies a subdomain that elicits transmission blocking antibodies. | Q47829675 |
| | Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite | Q47836839 |
| | Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230. | Q47850151 |
| | CD36-dependent adhesion and knob expression of the transmission stages of Plasmodium falciparum is stage specific. | Q47850905 |
| | Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry | Q47915916 |
| | Role of T cells in preventing transmission of rodent malaria | Q47925772 |
| | A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230. | Q47930799 |
| | Evidence for cyclic development and short-lived maturity in the gametocytes of Plasmodium falciparum | Q47956702 |
| | Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum. | Q48003662 |
| | Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose | Q48004480 |
| | Production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expressing bacterial PNGase F. | Q48007592 |
| | Strain polymorphism of Plasmodium falciparum transmission-blocking target antigen Pfs230. | Q48014503 |
| | Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission | Q48021662 |
| | Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum | Q48103837 |
| | Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity | Q49732059 |
| | Detecting gametocytes: how sensitive is sensible? | Q50138673 |
| | Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites. | Q54978998 |
| | Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period. | Q55381231 |
| | Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission. | Q55563437 |
| | Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults | Q56337991 |
| | Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults | Q56342219 |
| | Regulation of Sexual Commitment and Gametocytogenesis in Malaria Parasites | Q56365794 |
| | Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody | Q57154118 |
| | Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures | Q68897064 |
| | Gametocytogenesis of Plasmodium falciparum in vitro: an electron microscopic study | Q70221465 |
| P433 | issue | 6 | |
| P921 | main subject | Transmission-blocking vaccines. | Q34680152 |
| | Plasmodium falciparum | Q90813889 |
| | gametocytogenesis | Q60586439 |
| P577 | publication date | 2019-01-01 | |
| | 2019-05-21 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Transmission-Blocking Vaccines: Old Friends and New Prospects | |
| P478 | volume | 87 | |